Literature DB >> 6527706

Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration.

C Lillie, W Kobinger.   

Abstract

The effects of the two "specific bradycardic agents" AQ-A 39 and alinidine on the spontaneous electrical discharge rate of intact guinea-pig sinus node preparations were investigated. At high external K+-concentrations (10.8 and 16.2 mmol/l) the bradycardic effect of the two drugs was diminished or abolished. In contrast, the negative chronotropic effect of the reference compound verapamil ("Ca2+-antagonist") was enhanced. These results show that the bradycardic effects of AQ-A 39 and alinidine are diminished in depolarized preparations, which makes it unlikely that in intact sinus node preparations the mechanism of action is the same as that of "Ca2+-antagonists".

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527706     DOI: 10.1007/bf00512075

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Inward current activated during hyperpolarization in the rabbit sinoatrial node cell.

Authors:  K Yanagihara; H Irisawa
Journal:  Pflugers Arch       Date:  1980-05       Impact factor: 3.657

2.  The electrophysiological basis of the bradycardic action of AQA 39 on the sinoatrial node.

Authors:  W Osterrieder; D Pelzer; Q F Yang; W Trautwein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

3.  Electrophysiological studies on effects of AQ-A 39 in the isolated guinea pig heart and myocardial preparations.

Authors:  S Hohnloser; J Weirich; H Homburger; H Antoni
Journal:  Arzneimittelforschung       Date:  1982

4.  Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions.

Authors:  C Lillie; W Kobinger
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

Review 5.  Electrophysiology of the sinoatrial node.

Authors:  H F Brown
Journal:  Physiol Rev       Date:  1982-04       Impact factor: 37.312

6.  Temperature dependence of the chronotropic actions of calcium: functional inhomogeneity of the rabbit sinus node.

Authors:  A J Mackaay; W K Bleeker; T O Hof; L N Bouman
Journal:  J Mol Cell Cardiol       Date:  1980-05       Impact factor: 5.000

7.  Interactions of K, Na, and vagal stimulation in the S-A node of the rabbit.

Authors:  N Toda; T C West
Journal:  Am J Physiol       Date:  1967-02

8.  The effects of the bradycardia-producing compound alinidine on action potentials and tension development in cardiac fibres.

Authors:  H A Tritthart; H Windisch; S Heuberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

9.  Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist.

Authors:  J S Millar; E M Williams
Journal:  Cardiovasc Res       Date:  1981-06       Impact factor: 10.787

10.  Interaction of adrenaline and acetylcholine on cardiac pacemaker function. Functional inhomogeneity of the rabbit sinus node.

Authors:  A J Mackaay; T Op't Hof; W K Bleeker; H J Jongsma; L N Bouman
Journal:  J Pharmacol Exp Ther       Date:  1980-08       Impact factor: 4.030

  10 in total
  3 in total

1.  Modulation of EPSP shape and efficacy by intrinsic membrane conductances in rat neocortical pyramidal neurons in vitro.

Authors:  A Nicoll; A Larkman; C Blakemore
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

2.  On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49.

Authors:  T Doerr; W Trautwein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

3.  Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.

Authors:  C Lillie; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.